Home208340 • KOSDAQ
add
PharmAbcine Inc
Previous close
₩2,915.00
Year range
₩918.00 - ₩4,630.00
Market cap
76.32B KRW
P/E ratio
-
Dividend yield
-
Primary exchange
KOSDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (KRW) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.58B | -9.47% |
Net income | -2.27B | 56.92% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -2.36B | 11.08% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (KRW) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 16.20B | -12.29% |
Total assets | 24.84B | -23.10% |
Total liabilities | 6.56B | -60.14% |
Total equity | 18.28B | — |
Shares outstanding | 80.19M | — |
Price to book | 5.87 | — |
Return on assets | -27.98% | — |
Return on capital | -32.19% | — |
Cash Flow
Net change in cash
| (KRW) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -2.27B | 56.92% |
Cash from operations | -2.05B | -25.64% |
Cash from investing | 259.43M | -90.46% |
Cash from financing | 4.56B | 5,206.39% |
Net change in cash | 3.04B | 203.50% |
Free cash flow | -1.29B | -148.55% |
About
CEO
Founded
2008
Website
Employees
33
